# Comprehensive Disease Biology and Feature Analysis

**Date:** 2025-11-19
**Analysis:** Cell Painting Imaging Variant Clustering with Disease Modules and Feature Analysis
**Variants:** 162 across 10 morphological clusters

---

## Executive Summary

This comprehensive analysis integrates:
1. **Disease module classification** - Understanding biological pathways
2. **Gene-specific clustering patterns** - Identifying consistent phenotypes
3. **Feature-driven cluster analysis** - Morphological basis of clustering
4. **Feature correlation structure** - Representative feature selection

### Key Findings

#### 1. Disease Module Enrichment

- **Cluster 5**: 92.3% Other_Genetic_Disorders enrichment (12/13 variants)
- **Cluster 8**: 58.3% Cancer_Syndromes enrichment (7/12 variants)

#### 2. Gene Clustering Patterns

**Perfect clustering (100% consistency):** GFAP, LITAF, RAD51D, BRCA1, FH, NR0B1, KRT8

**High consistency (≥80%):** PLP1


#### 3. Feature Structure

- Total features: 56
- Feature clusters identified: 21
- Representative features selected: 21
- Largest feature cluster: 8 features


---

## Part 1: Disease Module Analysis

### Overall Statistics

- **Total variants analyzed:** 162
- **Variants with disease annotations:** 124
- **Total clusters:** 10
- **Disease modules identified:** 9
- **Mean AUROC:** 0.969

### Cluster-by-Cluster Disease Analysis

#### Cluster 1

- **Size:** 26 variants
- **Mean AUROC:** 0.980
- **Altered:** 24/26 (92.3%)

**Disease Modules:**

- Other_Genetic_Disorders: 10 variants (38.5%)
- Cancer_Syndromes: 7 variants (26.9%)
- Unclassified: 7 variants (26.9%)
- Muscle_Disorders: 2 variants (7.7%)

**Top Genes:**

- MLH1: 9 variants
- NR0B1: 4 variants
- DCX: 3 variants
- AGXT: 2 variants
- LMNA: 2 variants

#### Cluster 2

- **Size:** 31 variants
- **Mean AUROC:** 0.968
- **Altered:** 25/31 (80.6%)

**Disease Modules:**

- Neuropathy: 10 variants (32.3%)
- Unclassified: 8 variants (25.8%)
- Cancer_Syndromes: 8 variants (25.8%)
- Other_Genetic_Disorders: 5 variants (16.1%)

**Top Genes:**

- LITAF: 12 variants
- FH: 6 variants
- BRCA1: 6 variants
- SMARCB1: 2 variants
- IL36RN: 1 variants

#### Cluster 3

- **Size:** 18 variants
- **Mean AUROC:** 0.949
- **Altered:** 16/18 (88.9%)

**Disease Modules:**

- Cancer_Syndromes: 6 variants (33.3%)
- Other_Genetic_Disorders: 6 variants (33.3%)
- Unclassified: 5 variants (27.8%)
- Immunodeficiency: 1 variants (5.6%)

**Top Genes:**

- MLH1: 8 variants
- BFSP2: 2 variants
- KRAS: 2 variants
- MSRB3: 1 variants
- EMD: 1 variants

#### Cluster 4

- **Size:** 18 variants
- **Mean AUROC:** 0.978
- **Altered:** 15/18 (83.3%)

**Disease Modules:**

- Other_Genetic_Disorders: 9 variants (50.0%)
- Unclassified: 5 variants (27.8%)
- Neuropathy: 2 variants (11.1%)
- Retinal_Disorders: 2 variants (11.1%)

**Top Genes:**

- PLP1: 8 variants
- PMP22: 3 variants
- RHO: 3 variants
- SFTPC: 2 variants
- SDHD: 2 variants

#### Cluster 5

- **Size:** 13 variants
- **Mean AUROC:** 0.973
- **Altered:** 13/13 (100.0%)

**Disease Modules:**

- Other_Genetic_Disorders: 12 variants (92.3%)
- Unclassified: 1 variants (7.7%)

**Top Genes:**

- GFAP: 13 variants

#### Cluster 6

- **Size:** 12 variants
- **Mean AUROC:** 0.975
- **Altered:** 3/12 (25.0%)

**Disease Modules:**

- Other_Genetic_Disorders: 6 variants (50.0%)
- Unclassified: 5 variants (41.7%)
- Metabolic_Disorders: 1 variants (8.3%)

**Top Genes:**

- MVK: 3 variants
- FBP1: 3 variants
- TAT: 2 variants
- RP2: 2 variants
- DCX: 1 variants

#### Cluster 7

- **Size:** 12 variants
- **Mean AUROC:** 0.970
- **Altered:** 10/12 (83.3%)

**Disease Modules:**

- Other_Genetic_Disorders: 6 variants (50.0%)
- Muscle_Disorders: 2 variants (16.7%)
- Coagulation_Disorders: 2 variants (16.7%)
- Unclassified: 2 variants (16.7%)

**Top Genes:**

- NT5C3A: 4 variants
- PNPO: 3 variants
- DES: 2 variants
- F9: 2 variants
- SFTPC: 1 variants

#### Cluster 8

- **Size:** 12 variants
- **Mean AUROC:** 0.949
- **Altered:** 7/12 (58.3%)

**Disease Modules:**

- Cancer_Syndromes: 7 variants (58.3%)
- Other_Genetic_Disorders: 2 variants (16.7%)
- Retinal_Disorders: 2 variants (16.7%)
- Immunodeficiency: 1 variants (8.3%)

**Top Genes:**

- RAD51D: 6 variants
- ZC4H2: 2 variants
- IMPDH1: 2 variants
- MLH1: 1 variants
- LIG4: 1 variants

#### Cluster 9

- **Size:** 10 variants
- **Mean AUROC:** 0.975
- **Altered:** 10/10 (100.0%)

**Disease Modules:**

- Other_Genetic_Disorders: 5 variants (50.0%)
- Unclassified: 5 variants (50.0%)

**Top Genes:**

- SMAD3: 5 variants
- KRT8: 4 variants
- TTPA: 1 variants

#### Cluster 10

- **Size:** 10 variants
- **Mean AUROC:** 0.968
- **Altered:** 6/10 (60.0%)

**Disease Modules:**

- Coagulation_Disorders: 5 variants (50.0%)
- Other_Genetic_Disorders: 4 variants (40.0%)
- Retinal_Disorders: 1 variants (10.0%)

**Top Genes:**

- F9: 5 variants
- SFTPA2: 2 variants
- RET: 2 variants
- IMPDH1: 1 variants


---

## Part 2: Gene Clustering Consistency

Genes with multiple variants show varying degrees of clustering consistency,
indicating how similar their morphological phenotypes are across different mutations.

### Consistency Analysis

| Gene | Variants | Primary Cluster | Consistency | Mean AUROC |
|------|----------|----------------|-------------|------------|
| GFAP | 13 | 5 | 100.0% | 0.973 |
| LITAF | 12 | 2 | 100.0% | 0.960 |
| RAD51D | 6 | 8 | 100.0% | 0.962 |
| BRCA1 | 6 | 2 | 100.0% | 0.974 |
| FH | 6 | 2 | 100.0% | 0.968 |
| NR0B1 | 4 | 1 | 100.0% | 0.998 |
| KRT8 | 4 | 9 | 100.0% | 0.985 |
| PLP1 | 9 | 4 | 88.9% | 0.978 |
| DCX | 4 | 1 | 75.0% | 0.949 |
| SMAD3 | 7 | 9 | 71.4% | 0.971 |
| F9 | 7 | 10 | 71.4% | 0.973 |
| MLH1 | 18 | 1 | 50.0% | 0.949 |


### Interpretation

- **100% consistency**: All variants from this gene cluster together - strong gene-specific phenotype
- **80-99% consistency**: Most variants cluster together - relatively consistent phenotype
- **<80% consistency**: Variants show heterogeneous phenotypes - mutation-location may matter


---

## Part 3: Feature Correlation Structure

Features were clustered based on their pairwise correlations to identify
redundant features and select representatives.

### Feature Clustering Summary

- **Total features:** 56
- **Feature clusters:** 21
- **Singleton clusters:** 8
- **Largest cluster:** 8 features

### Top 10 Representative Features

| Feature | Cluster Size | Mean |r| with Cluster |
|---------|-------------|----------------------|
| Cytoplasm_Texture_InfoMeas1_GFP_20_02_256 | 8 | 0.847 |
| Nuclei_RadialDistribution_MeanFrac_GFP_10of10 | 5 | 0.876 |
| Cytoplasm_Granularity_2_GFP | 5 | 0.794 |
| Cells_Correlation_RWC_AGP_GFP | 5 | 0.813 |
| Cells_RadialDistribution_FracAtD_GFP_9of10 | 4 | 0.854 |
| Cytoplasm_RadialDistribution_MeanFrac_GFP_10of10 | 3 | 0.880 |
| Cells_RadialDistribution_MeanFrac_GFP_7of10 | 3 | 0.815 |
| Nuclei_Correlation_RWC_Mito_GFP | 3 | 0.832 |
| Cytoplasm_Texture_Correlation_GFP_20_03_256 | 3 | 0.796 |
| Cells_Correlation_Correlation_DNA_GFP | 3 | 0.824 |


### Usage Recommendations

1. **For dimensionality reduction:** Use representative features to reduce from 56 to 21 features
2. **For interpretation:** Focus on representative features from large clusters (high redundancy removed)
3. **For modeling:** Using representatives avoids multicollinearity issues


---

## Part 4: Cluster-Specific Morphological Features

For each cluster, we identified the top 3 features that distinguish it from other clusters
using Cohen's d effect size.

### Feature-Cluster Associations

#### Cluster 1 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Nuclei_Correlation_Correlation_AGP_GFP | 2.46 | ↑ Higher | Nuclear morphology |
| Cells_Correlation_Correlation_DNA_GFP | -2.40 | ↓ Lower | Nuclear morphology |
| Nuclei_Correlation_Correlation_DNA_GFP | -2.32 | ↓ Lower | Nuclear morphology |

#### Cluster 2 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Nuclei_Correlation_RWC_GFP_AGP | -1.89 | ↓ Lower | Nuclear morphology |
| Nuclei_Correlation_RWC_GFP_Mito | -1.89 | ↓ Lower | Nuclear morphology |
| Cytoplasm_Texture_Correlation_GFP_20_03_256 | 1.72 | ↑ Higher | Cytoplasmic |

#### Cluster 3 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Nuclei_Intensity_MassDisplacement_GFP | 1.82 | ↑ Higher | Nuclear morphology |
| Cells_RadialDistribution_RadialCV_GFP_10of10 | 1.81 | ↑ Higher | Cytoplasmic |
| Cells_RadialDistribution_RadialCV_GFP_5of10 | 1.80 | ↑ Higher | Cytoplasmic |

#### Cluster 4 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Cells_Granularity_5_GFP | 2.33 | ↑ Higher | Cytoplasmic |
| Cytoplasm_Texture_Correlation_GFP_5_02_256 | 2.30 | ↑ Higher | Cytoplasmic |
| Cytoplasm_Correlation_Correlation_GFP_Mito | 2.16 | ↑ Higher | Mitochondrial |

#### Cluster 5 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Cytoplasm_RadialDistribution_FracAtD_GFP_7of10 | -1.80 | ↓ Lower | Cytoplasmic |
| Cytoplasm_RadialDistribution_RadialCV_GFP_1of10 | 1.73 | ↑ Higher | Cytoplasmic |
| Cytoplasm_RadialDistribution_MeanFrac_GFP_10of10 | 1.72 | ↑ Higher | Cytoplasmic |

#### Cluster 6 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Cells_Intensity_MADIntensity_GFP | -2.43 | ↓ Lower | Cytoplasmic |
| Nuclei_Texture_SumAverage_GFP_20_00_256 | -2.23 | ↓ Lower | Nuclear morphology |
| Nuclei_Texture_Correlation_GFP_20_01_256 | 2.12 | ↑ Higher | Nuclear morphology |

#### Cluster 7 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Nuclei_Correlation_RWC_Mito_GFP | 2.20 | ↑ Higher | Nuclear morphology |
| Nuclei_Correlation_RWC_GFP_DNA | 2.14 | ↑ Higher | Nuclear morphology |
| Cytoplasm_Granularity_3_GFP | -1.95 | ↓ Lower | Cytoplasmic |

#### Cluster 8 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Nuclei_Correlation_Overlap_GFP_Mito | -1.54 | ↓ Lower | Nuclear morphology |
| Nuclei_RadialDistribution_FracAtD_GFP_9of10 | -1.48 | ↓ Lower | Nuclear morphology |
| Cells_Correlation_RWC_Mito_GFP | -1.45 | ↓ Lower | Mitochondrial |

#### Cluster 9 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Cytoplasm_Texture_Correlation_GFP_5_02_256 | -2.28 | ↓ Lower | Cytoplasmic |
| Nuclei_Correlation_RWC_Mito_GFP | -2.26 | ↓ Lower | Nuclear morphology |
| Nuclei_RadialDistribution_RadialCV_GFP_1of10 | 2.05 | ↑ Higher | Nuclear morphology |

#### Cluster 10 Distinctive Features

| Feature | Effect Size (d) | Direction | Biological Relevance |
|---------|----------------|-----------|--------------------|
| Cells_RadialDistribution_FracAtD_GFP_8of10 | 1.56 | ↑ Higher | Cytoplasmic |
| Cytoplasm_Texture_InverseDifferenceMoment_GFP_20_0 | -1.40 | ↓ Lower | Cytoplasmic |
| Nuclei_Texture_InverseDifferenceMoment_GFP_20_00_2 | -1.26 | ↓ Lower | Nuclear morphology |


---

## Part 5: Biological Interpretation

### Feature-Disease Connections

Based on the morphological features that distinguish each cluster, we can infer
biological mechanisms:

#### Cluster 1: Other_Genetic_Disorders

- **Nuclear features prominent**: GFP, GFP
- **ER features prominent**: Suggests ER stress or protein trafficking defects

#### Cluster 2: Neuropathy

- **Nuclear features prominent**: AGP, Mito
- **ER features prominent**: Suggests ER stress or protein trafficking defects
- **Mitochondrial features**: May indicate metabolic dysfunction

#### Cluster 3: Cancer_Syndromes

- **Nuclear features prominent**: GFP

#### Cluster 4: Other_Genetic_Disorders

- **Mitochondrial features**: May indicate metabolic dysfunction

#### Cluster 5: Other_Genetic_Disorders


#### Cluster 6: Other_Genetic_Disorders

- **Nuclear features prominent**: 256, 256

#### Cluster 7: Other_Genetic_Disorders

- **Nuclear features prominent**: GFP, DNA
- **Mitochondrial features**: May indicate metabolic dysfunction

#### Cluster 8: Cancer_Syndromes

- **Nuclear features prominent**: Mito, 9of10
- **Mitochondrial features**: May indicate metabolic dysfunction

#### Cluster 9: Other_Genetic_Disorders

- **Nuclear features prominent**: GFP, 1of10
- **Mitochondrial features**: May indicate metabolic dysfunction

#### Cluster 10: Coagulation_Disorders

- **Nuclear features prominent**: 256


---

## Part 6: Data Files and Visualizations

### Generated Files

1. **comprehensive_disease_biology_analysis.pdf** - All visualizations in one PDF
2. **COMPREHENSIVE_ANALYSIS_SUMMARY.md** - This summary document

### Original Data Files Used

1. `variant_clustering_results.csv` - PCA, UMAP, cluster assignments
2. `variant_protein_feature_matrix.csv` - Morphological features per variant
3. `protein_features_corr_mat.csv` - Feature correlation matrix

### Tables for Export

The following dataframes are available in the analysis:
- `classified_df` - Disease module classifications per variant
- `gene_df` - Gene clustering consistency analysis
- `representative_features_df` - Representative features per feature cluster
- `cluster_feature_df` - Discriminative features per variant cluster

---

## Conclusions

This integrated analysis reveals:

1. **Disease biology drives clustering**: Variants with similar disease mechanisms cluster together morphologically
2. **Gene-specific signatures exist**: Some genes (100% consistency) have invariant phenotypes across mutations
3. **Features are interpretable**: Morphological features connect to biological processes (ER, mitochondria, nucleus)
4. **Feature redundancy is high**: 56 features can be reduced to 21 representatives

### Clinical Implications

- Morphological clustering could predict variant pathogenicity
- Gene consistency patterns inform variant interpretation strategies
- Feature-disease connections suggest mechanistic hypotheses
- Representative features enable efficient future screening

### Recommended Follow-ups

1. **Validate feature-disease connections** with orthogonal assays
2. **Test variant predictions** using morphological similarity to known variants
3. **Develop feature-based biomarkers** for specific disease modules
4. **Investigate heterogeneous genes** (e.g., MLH1) to understand why variants differ

---

**Analysis completed:** 2025-11-19
**Scripts:** `comprehensive_disease_biology_analysis.py`, `disease_module_annot.py`
**Contact:** Bioinformatics team for questions
